Aillis, Inc.

Aillis, Inc. is a Japan-based startup that is revolutionizing influenza detection with its AI driven medical device. Founded in 2017, the company is focused on leveraging machine-learning to enable easy, accurate, and early detection of influenza using pharyngeal images instead of traditional specimen collection by swab. Their slogan "AI powered medical device for early and accurate influenza detection" reflects their commitment to using cutting-edge technology for healthcare innovation. Aillis, Inc. operates in the Information Technology sector and received a significant Venture Round investment from MITSUI SUMITOMO INSURANCE Venture Capital (MSIVC) on 01 January 2022. This latest investment signifies confidence from a notable investor and underscores the potential of Aillis, Inc. in the healthcare technology space.